Nova Mentis Life Science (TSE:NOVA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nova Mentis Life Science Corp. has announced an agreement to assign its intellectual property related to the mRNA Neuro Panel and Serotonin Assay to Ludwig Enterprises Inc. The deal includes debt forgiveness, stock issuance, and future royalties on commercialized revenue for NOVA. Amidst challenges in its Phase 2a clinical trial and the broader psychedelic sector, NOVA is seeking new business opportunities to enhance shareholder value.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.